Goodyear Delivers $105 Million: Q4 Profit and Investor Boost
Goodyear reports a strong Q4 with $105 million in profit, while an investor increases exposure to $15 million. This p...
Which To Choose For Retirement 2024 Index Fund Or Tdf
We compare the 2024 outlook for index funds and target date funds to help you choose the right retirement path.
23,982 articles
President Trump Claims Tariffs Could Replace Income Tax
Tariffs are a powerful tool, but can they really replace the income tax? This analysis dives into the economics, data...
Netflix Backs Warner Bros. Deal: 5 Smart Moves for Investors
Netflix backed away from a Warner Bros. deal, signaling a calculated shift in strategy. Here are five practical reaso...
Figma Stock Shot February: What Investors Should Know
In February, Figma exhibited a notable stock move as investor interest focused on cloud-based collaboration tools. Th...
Travis Scott Powerhouse Coalition Faces Supreme Court
A coalition of rap legends led by Travis Scott takes a bold legal stand at the Supreme Court. This isn’t just a court...
Biote (BTMD) 2026 Earnings: Outlook and Takeaways Today
Biote's Q1 2026 earnings call reveals critical insights into revenue growth, margins, and a promising pipeline. This ...
Daré (Dare) 2026 Earnings: A Comprehensive Investor Guide
As Daré gears up to discuss Q1 2026 results, investors will scrutinize cash runway, pipeline milestones, and strategi...
Jaguar (JAGX) 2025 Earnings: Strategy and Investor Outlook
Jaguar (JAGX) 2025 earnings show a company shifting from product-driven revenue to licensing cash. This piece breaks ...
President Trump's Drug Pricing Policy and Pharma Stocks
Policy shifts around president trump's drug pricing could squeeze pharma profits and shift stock dynamics. This guide...
That Doubled 2026 Caught: Oil ETF in Supply, Capacity Split
The oil ETF that doubled in 2026 is navigating a renewed tug of war between supply shocks and capacity restoration. H...
Merck: Navigating Patent Cliff and Growth Prospects
Merck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status